Skip to content
brainology

Neurology and Brain Health

Burning Feet but a Normal EMG? Understanding Small Fiber Neuropathy

A normal EMG does not rule out every neuropathy. Small fiber neuropathy affects pain, temperature, and autonomic fibers that routine nerve-conduction studies may not measure well.

Conceptual illustration for small fiber neuropathy, with themes of Small fibers, Large fibers and Targeted evaluation.
Brainology editorial illustration. Conceptual, not a patient recording or diagnostic image.

Burning, prickling, or electric pain in the feet can feel unmistakably neurologic. Yet some people undergo electromyography and nerve-conduction studies, often referred to together as an EMG, and are told that the results are normal.

That does not mean the symptoms are imaginary. It also does not automatically establish small fiber neuropathy. The result may simply mean that the large nerve fibers tested by routine electrodiagnostic studies are functioning within the expected range.

Small fiber neuropathy requires a different diagnostic approach. Understanding what each test measures can help patients avoid both premature dismissal and premature diagnosis.

What are small nerve fibers?

Peripheral nerves contain fibers with different jobs. Larger, heavily insulated fibers carry signals related to muscle activation, vibration, position sense, and reflexes. Small fibers include thinly myelinated A-delta fibers and unmyelinated C fibers. They help transmit pain and temperature and also participate in automatic functions such as sweating, blood-vessel control, heart-rate regulation, and gastrointestinal activity.[1]

When small fibers are damaged or malfunctioning, symptoms may include:

  • Burning, stabbing, shooting, or electric pain
  • Tingling or pins-and-needles sensations
  • Reduced ability to feel heat, cold, or a pinprick
  • Pain from light touch, socks, or bedcovers
  • Altered sweating or heat tolerance
  • Lightheadedness when standing
  • Changes in bowel, bladder, or sexual function

Autonomic symptoms have many possible causes, so their presence alone does not prove that small fiber neuropathy is responsible.

Why can the EMG be normal?

Standard nerve-conduction studies stimulate and record electrical signals traveling through relatively large myelinated nerves. Needle EMG examines electrical activity within selected muscles. These tests are valuable for detecting large-fiber polyneuropathy, pinched nerves, entrapment neuropathies, motor-neuron disorders, and muscle disease.

The smallest pain and autonomic fibers do not generate signals that routine nerve-conduction studies capture reliably. Therefore, a person with isolated small fiber neuropathy may have normal nerve-conduction results and a normal needle examination.

An EMG can still be important. It may uncover a different explanation, show that both small and large fibers are involved, or identify a radiculopathy such as a compressed spinal nerve. A normal result narrows the question. It does not answer it by itself.

What pattern suggests small fiber neuropathy?

The classic pattern begins in the toes and feet, gradually moving upward in a length-dependent “stocking” distribution. If symptoms progress far enough, the fingertips may become involved. Pain is often worse at night, and some people notice abnormal sensitivity to temperature or light contact.

Not every case follows that pattern. Symptoms can be patchy, asymmetric, involve the trunk or face, or appear in several regions without starting in the feet. These non-length-dependent presentations may prompt evaluation for immune, inflammatory, sensory-ganglion, or other causes.

Symptoms alone are not sufficiently specific. In a 2019 validation study, researchers found that combining clinical signs with abnormal quantitative sensory testing or reduced intraepidermal nerve-fiber density was more reliable than relying on symptoms or an isolated abnormal test.[2]

What does a skin biopsy show?

A skin biopsy for small fiber neuropathy is usually a 3-millimeter punch biopsy performed with local anesthetic, commonly near the ankle. Some evaluations also include a second sample from the thigh. A laboratory stains the tissue and counts intraepidermal nerve fibers, then compares the density with appropriate reference values.

Professional guidance recognizes distal-leg skin biopsy with standardized nerve-fiber counting as a reliable method for supporting the diagnosis of small fiber neuropathy.[3] It provides structural evidence that small sensory fibers are reduced.

The test has limits. A low density supports small fiber loss but does not identify the cause. A normal biopsy does not exclude every case, particularly when symptoms are early, patchy, or predominantly autonomic, or when sampling and reference methods differ. Results must be interpreted alongside the neurologic examination and symptom pattern.

Are there other useful tests?

Quantitative sensory testing measures a person's detection of warm, cold, or painful stimuli. It evaluates function, but it depends on attention and participation and should not generally stand alone as proof of neuropathy.

Autonomic testing may be helpful when symptoms suggest abnormal sweating, blood-pressure regulation, or other autonomic dysfunction. Tests can include the quantitative sudomotor axon reflex test, heart-rate responses to breathing, and blood-pressure responses during tilt or other maneuvers. An American Academy of Neurology practice parameter advises considering autonomic testing for suspected autonomic neuropathy and distal small fiber sensory polyneuropathy, with a validated battery preferred when available.[4]

No single test is perfect. The most credible diagnosis comes from agreement among the history, examination, distribution of symptoms, objective testing, and exclusion of a better explanation.

What causes small fiber neuropathy?

Diabetes is an important and common cause, but the evaluation should not stop there. Depending on the history and examination, clinicians may consider impaired glucose regulation, vitamin B12 deficiency, thyroid disease, kidney or liver disease, alcohol exposure, medication or chemotherapy toxicity, HIV or hepatitis C, celiac disease, Sjögren disease, sarcoidosis, monoclonal proteins, amyloidosis, and selected inherited disorders.

A 2025 peer-reviewed review proposed a structured laboratory approach that begins with common metabolic and immune causes, followed by targeted second-line testing when clinical clues warrant it.[5] This is preferable to ordering every possible test for every patient. Family history, age at onset, rate of progression, autonomic involvement, systemic symptoms, medication exposure, and examination findings should shape the workup.

Sometimes no cause is found even after an appropriate evaluation. This is called idiopathic small fiber neuropathy. “Idiopathic” describes the limits of current knowledge; it does not mean the symptoms are not real.

How is it treated?

Treatment has two goals: address an identifiable cause and reduce symptoms. Correcting a deficiency, improving diabetes management, removing a neurotoxic exposure when possible, or treating a confirmed systemic disorder may help prevent further injury. Recovery varies because damaged fibers may regenerate slowly and not always completely.

Neuropathic pain treatment is individualized. Options can include certain antidepressants, gabapentinoids, sodium-channel blockers, and topical agents. Selection depends on other medical conditions, sleep, mood, fall risk, medication interactions, and side effects. These medicines manage pain signals; they do not necessarily repair nerves.

Immunotherapy should not be assumed to help merely because an autoimmune mechanism is suspected. In a randomized, placebo-controlled trial of 60 patients with painful idiopathic small fiber neuropathy, intravenous immunoglobulin did not significantly reduce pain or improve the other prespecified outcomes.[6] That finding does not resolve treatment for every defined autoimmune disorder, but it argues against routine IVIG for idiopathic painful small fiber neuropathy.

Regular movement, foot protection, appropriate footwear, and attention to sleep and mood can also support function. People with reduced sensation should check their feet for blisters, burns, and wounds they may not feel normally.

When should symptoms be evaluated promptly?

Seek timely medical attention for rapidly progressing symptoms, substantial weakness, repeated falls, marked asymmetry, new bowel or bladder dysfunction, fainting, unexplained weight loss, fever, or symptoms beginning after a new medication or toxic exposure. Sudden one-sided weakness, facial drooping, speech difficulty, or abrupt loss of coordination requires emergency evaluation for stroke rather than an outpatient neuropathy workup.

The bottom line

A normal EMG can coexist with small fiber neuropathy because routine electrodiagnostic testing primarily examines larger fibers. However, normal testing should not be treated as automatic proof of a small fiber disorder.

The diagnosis is strongest when the symptom pattern, neurologic examination, and objective small-fiber testing point in the same direction. The next step is then to look thoughtfully for an underlying cause and create a treatment plan that addresses both nerve health and symptom control.

If persistent burning, tingling, temperature loss, or autonomic symptoms remain unexplained, Brainology can provide a neurologic assessment and help determine whether electrodiagnostic studies, skin biopsy, autonomic testing, laboratory evaluation, or another approach is appropriate.

This draft is for educational purposes and is not a substitute for individualized medical advice, diagnosis, or emergency care. It should undergo clinical and editorial review before publication.

References

  1. National Institute of Neurological Disorders and Stroke. Peripheral Neuropathy. Updated March 13, 2026. NINDS

  2. Devigili G, Rinaldo S, Lombardi R, et al. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain. 2019;142(12):3728-3736. PubMed | Full text

  3. Lauria G, Hsieh ST, Johansson O, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. European Journal of Neurology. 2010;17(7):903-912, e44-e49. PubMed | DOI

  4. England JD, Gronseth GS, Franklin G, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy. Neurology. 2009;72(2):177-184. PubMed | DOI

  5. Lefaucheur JP, et al. A structured list of laboratory tests for screening the possible causes of small fiber neuropathy in clinical practice. Frontiers in Neurology. 2025;16:1679316. Full text | DOI

  6. Geerts M, de Greef BTA, Sopacua M, et al. Intravenous immunoglobulin therapy in patients with painful idiopathic small fiber neuropathy. Neurology. 2021;96(20):e2534-e2545. PubMed | Full text

  7. Tavee JO. Office approach to small fiber neuropathy. Cleveland Clinic Journal of Medicine. 2018;85(10):801-812. Full text | PubMed